News Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting by Trophic 21 April, 2026
News PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma by Trophic 17 April, 2026
News Immatics Announces Full Year 2025 Financial Results and Business Update by Trophic 05 March, 2026
